Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

proliferation

  • Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, <sup>18</sup>F-FMISO PET, and <sup>18</sup>F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
    Open Access
    Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, 18F-FMISO PET, and 18F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
    Solène Collet, Jean-Sébastien Guillamo, David Hassanein Berro, Ararat Chakhoyan, Jean-Marc Constans, Emmanuèle Lechapt-Zalcman, Jean-Michel Derlon, Mathieu Hatt, Dimitris Visvikis, Stéphane Guillouet, Cécile Perrio, Myriam Bernaudin and Samuel Valable
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1349-1356; DOI: https://doi.org/10.2967/jnumed.120.249524
  • Open Access
    Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using 18F-ICMT-11 and 18F-FLT PET
    Kathrin Heinzmann, Quang-Dé Nguyen, Davina Honess, Donna-Michelle Smith, Stephen Stribbling, Diana Brickute, Chris Barnes, John Griffiths and Eric Aboagye
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1558-1565; DOI: https://doi.org/10.2967/jnumed.118.209304
  • You have access
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
    Laura Kenny
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 89S-95S; DOI: https://doi.org/10.2967/jnumed.115.157958
  • You have access
    Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model
    David A. Rendon, Khushali Kotedia, Solmaz F. Afshar, Jyotinder N. Punia, Omaima M. Sabek, Beverly A. Shirkey, Janice A. Zawaski and M. Waleed Gaber
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 266-271; DOI: https://doi.org/10.2967/jnumed.115.158121
  • You have access
    18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study
    Elise M. Blanchet, David Taieb, Corina Millo, Victoria Martucci, Clara C. Chen, Maria Merino, Peter Herscovitch and Karel Pacak
    Journal of Nuclear Medicine December 1, 2015, 56 (12) 1849-1854; DOI: https://doi.org/10.2967/jnumed.115.159061
  • You have access
    PET Imaging of Proliferation with Pyrimidines
    Omid S. Tehrani and Anthony F. Shields
    Journal of Nuclear Medicine June 1, 2013, 54 (6) 903-912; DOI: https://doi.org/10.2967/jnumed.112.112201
  • You have access
    3′-Deoxy-3′-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
    Eliot T. McKinley, R. Adam Smith, Ping Zhao, Allie Fu, Samir A. Saleh, Md. Imam Uddin, M. Kay Washington, Robert J. Coffey and H. Charles Manning
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.112.108456
  • You have access
    Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas
    Yuka Yamamoto, Yuko Ono, Fumitoshi Aga, Nobuyuki Kawai, Nobuyuki Kudomi and Yoshihiro Nishiyama
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1911-1915; DOI: https://doi.org/10.2967/jnumed.112.104729
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire